Thuja Capital

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.

Pan Cancer exploits 20 years of pioneering research in the field of adoptive T-cell therapies.

Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA

Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.

FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.